News

September 21, 2021

Edesa finds a signal in severely ill Covid-19 patients

But other small biotechs are more advanced and still hope to play a role in the pandemic.

September 21, 2021

Esmo 2021 – Beyondspring experiences winter of discontent

September 20, 2021

Pfizer/Biotech's Covid vaccine data looks good enough for FDA, but parents?

September 20, 2021

Holding back doesn’t lessen the pain for Protagonist

September 20, 2021

Mirati moves for an independent future

September 17, 2021

Esmo 2021 – look out Agenus, Keytruda is about to put up a roadblock

September 17, 2021

Esmo 2021 – poziotinib could add first-line string to its bow

September 17, 2021

Esmo 2021 – Mahogany loses its polish for Macrogenics

September 16, 2021

Aerie brushes off dry eye trial failure

Endpoints, schmendpoints.

September 15, 2021

Breakthrough device reimbursement rule on the rocks

Despite industry outcry, new data question how relevant the rule would have been anyway.

September 15, 2021

The other shoe drops for Theravance

Load More